Baxter China To Increase Rural Access To Renal Therapy

Baxter China has piloted a program to deploy a sustainable care and delivery model for peritoneal dialysis patients living in rural areas of the country.

AsianScientist (Apr. 8, 2013) – Baxter China has partnered with the Chinese National Institute of Hospital Administration under an endorsement from the Ministry of Health to develop and deploy a sustainable care and delivery model for peritoneal dialysis (PD) patients with end-stage renal disease (ESRD), or irreversible kidney failure, living in rural areas of the country.

The program, named “Flying Angel” for its intent to address the barriers to access for dialysis therapy in rural areas, piloted in six provinces beginning in early 2012.

It will focus on establishing a logistics distribution model, standards of care, public education programs, training for healthcare professionals, and improving affordability for patients.

Peritoneal dialysis is a home-based therapy in which patients infuse a solution through a surgically implanted catheter in their abdomen into their peritoneum, or abdominal cavity, where it draws waste products across the peritoneal membrane (which serves as a natural filter) into the solution.

China’s Ministry of Health ranked ESRD among the country’s top eight critical diseases in 2012. Currently only a minority of the estimated one million patients in China with ESRD receive regular treatment. The majority of ESRD patients in rural China have limited access to care and therapy due to low awareness levels of the disease and limited hospital infrastructure and personnel.

——

Source: Baxter China.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.

Asian Scientist Magazine is an award-winning science and technology magazine that highlights R&D news stories from Asia to a global audience. The magazine is published by Singapore-headquartered Wildtype Media Group.

Related Stories from Asian Scientist